Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms.
about
Emerging immunotherapies for glioblastomamiR-497 inhibits epithelial mesenchymal transition in breast carcinoma by targeting Slug.Nanomedicines for dysfunctional macrophage-associated diseases.Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model
P2860
Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Gene Therapy for the Treatment ...... tral Nervous System Neoplasms.
@ast
Gene Therapy for the Treatment ...... tral Nervous System Neoplasms.
@en
type
label
Gene Therapy for the Treatment ...... tral Nervous System Neoplasms.
@ast
Gene Therapy for the Treatment ...... tral Nervous System Neoplasms.
@en
prefLabel
Gene Therapy for the Treatment ...... tral Nervous System Neoplasms.
@ast
Gene Therapy for the Treatment ...... tral Nervous System Neoplasms.
@en
P2093
P2860
P1476
Gene Therapy for the Treatment ...... ntral Nervous System Neoplasms
@en
P2093
Marianela Candolfi
Mariela Moreno Ayala
Marta Dzaman
Neha Kamran
Pedro R Lowenstein
P2860
P304
P356
10.1007/978-1-4939-3271-9_31
P407
P577
2016-01-01T00:00:00Z